ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,600Medicare Part D Prescriptions Filled, Including Refills

Rank: 446 out of 4623

$643K Total Retail Price of All Prescriptions

Rank: 431 out of 4623

607 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

24% of this provider’s 607 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 7,630 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 532 364 S3 1 3
LISINOPRIL 401 268 2 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 373 268 3 19
AMLODIPINE BESYLATE 370 263 4 5
SIMVASTATIN 367 226 5 2
METFORMIN HCL 364 236 6 6
PRAVASTATIN SODIUM 357 265 7 11
METOPROLOL TARTRATE 260 205 8 9
LEVOTHYROXINE SODIUM 249 180 9 1
DOXYCYCLINE HYCLATE 242 151 10 101
FUROSEMIDE 206 140 11 8
TRAMADOL HCL 197 137 12 15
GABAPENTIN 161 114 13 16
OMEPRAZOLE 158 103 14 7
ALLOPURINOL 150 117 15 37
TRIAMTERENE-HCTZ 145 78 16 80
METOPROLOL SUCCINATE 145 113 16 13
POTASSIUM CHLORIDE 143 90 18 14
FAMOTIDINE 137 90 19 82
LOVAZA 121 95 20 112
NEXIUM 110 63 21 17
GLIMEPIRIDE 105 91 22 38
ATORVASTATIN CALCIUM 103 74 23 12
CRESTOR 98 77 24 20
CARVEDILOL 93 62 25 25
PROAIR HFA 90 58 26 64
HUMULIN 70-30 88 58 27 202
TRIAMCINOLONE ACETONIDE 83 56 28 124
DOXAZOSIN MESYLATE 82 63 29 98
WARFARIN SODIUM 79 57 30 24
RANITIDINE HCL 75 60 31 47
PREDNISONE 73 50 32 50
NOVOLIN R 72 70 33 113
NOVOLIN 70-30 72 53 33 153
SPIRIVA 69 55 35 79
CITALOPRAM HBR 68 51 36 23
ADVAIR DISKUS 66 38 37 62
HYDROCHLOROTHIAZIDE 65 45 38 10
ZOLPIDEM TARTRATE 64 45 39 18
POLYETHYLENE GLYCOL 3350 64 46 39 91
VENTOLIN HFA 61 44 41 134
VERAPAMIL ER 60 51 42 96
FINASTERIDE 60 55 42 109
DORZOLAMIDE-TIMOLOL 57 56 44 373
CYCLOBENZAPRINE HCL 54 0 R 45 53
FLUOXETINE HCL 54 47 45 61
CLOPIDOGREL 52 49 47 31
SERTRALINE HCL 52 31 47 26
LANTUS SOLOSTAR 51 42 49 105
LATANOPROST 51 51 49 224
QUETIAPINE FUMARATE 50 45 51 74
PLAVIX 50 49 51 45
TAMSULOSIN HCL 50 46 51 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 12, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.